Sugi Predict

Sugi Predict / Compounds / SCHEMBL2545199

SCHEMBL2545199

SCHEMBL2545199

COc1cc(O)cc(-c2ccccc2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 6/20 0.62
▸ ABL1 P00519 5/20 0.62
▸ BCR P11274 5/20 0.62
▸ TP53 P04637 2/20 0.62
▸ SMN1; SMN2 Q16637 2/20 0.62
▸ NPC1 O15118 2/20 0.62
▸ MAPK1 P28482 1/20 0.62
▸ CASP3 P42574 1/20 0.62
▸ RAB9A P51151 1/20 0.62
▸ SENP8 Q96LD8 1/20 0.62
▸ SENP7 Q9BQF6 1/20 0.62
▸ SENP6 Q9GZR1 1/20 0.62
▸ CYP3A4 P08684 3/20 0.58
▸ MAPT P10636 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ MEN1 O00255 1/20 0.58
▸ USP2 O75604 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ KMT2A Q03164 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26731305 0.86 ABL1 (0.84) ABCB1ABL1BCRTP53SMN1; SMN2
SCHEMBL29771944 0.86 ABL1 (0.84) ABCB1ABL1BCRTP53SMN1; SMN2
SCHEMBL2407878 0.85 CYP1A1 (0.74) ABCB1ABL1BCRSMN1; SMN2NPC1
SCHEMBL8987283 0.85 CYP1A1 (0.74) ABCB1ABL1BCRSMN1; SMN2NPC1
SCHEMBL26498639 0.81 CYP1A1 (0.83) ABCB1ABL1BCRSMN1; SMN2NPC1
SCHEMBL26498734 0.81 CYP1A1 (0.83) ABCB1ABL1BCRSMN1; SMN2NPC1
SCHEMBL26498789 0.81 CYP1A1 (0.83) ABCB1ABL1BCRSMN1; SMN2NPC1
Biphenyl SCHEMBL28999514 0.80 ESR1 (0.56) ABCB1ABL1BCRTP53SMN1; SMN2
SCHEMBL21296972 0.80 ABL1 (0.73) ABCB1ABL1BCRTP53SMN1; SMN2
SCHEMBL6068053 0.80 ABL1 (0.62) ABCB1ABL1BCRTP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530512-B2 Broad spectrum gram-positive antimicrobials and anthelmintics with efficacy against drug-resistant strains and Mycobacterium species MONTE AARON P (US) 2013-09-10 — — US disclosed
US-8178559-B2 Organic compounds NOVARTIS AG (CH) 2012-05-15 — — US disclosed
US-8084450-B2 Organic compounds NOVARTIS AG (CH) 2011-12-27 — — US disclosed
US-20110263560-A1 Organic Compounds NOVARTIS AG (CH) 2011-10-27 — — US disclosed
US-20110092578-A1 Broad Spectrum Gram-Positive Antimicrobials and Anthelmintics with Efficacy Against Drug-Resistant Strains and Mycobacterium Species MONTE AARON P 2011-04-21 — — US disclosed
EP-2177518-A1 Organic compounds Novartis AG (CH) 2010-04-21 — — EP disclosed
US-20100029647-A1 3,4,(5)-SUBSTITUTED TETRAHYDROPHYRIDINES NOVARTIS AG (CH) 2010-02-04 — — US disclosed
US-20090312304-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-12-17 — — US disclosed
EP-1833816-B1 SUBSTITUTED PIPERIDINES AS RENIN INHIBITORS NOVARTIS AG (CH) 2009-11-11 — — EP disclosed
EP-1841740-A1 3,4,(5)-SUBSTITUTED TETRAHVDROPYRIDINES Novartis AG (CH) 2007-10-10 — — EP disclosed
WO-2006074924-A1 3,4,(5)-SUBSTITUTED TETRAHVDROPYRIDINES NOVARTIS AG (CH) 2006-07-20 — — WO disclosed
WO-2006069788-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2006-07-06 — — WO disclosed
EP-1311257-B1 COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS INSMED INC (US) 2005-04-27 — — EP disclosed
EP-1311257-A2 COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS Insmed Incorporated (US) 2003-05-21 — — EP disclosed
US-6552085-B2 For lowering blood glucose in a mammal INSMED INCORPORATED 2003-04-22 — — US disclosed
US-6410596-B1 FOR LOWERING BLOOD GLUCOSE IN A MAMMAL INSMED INCORPORATED 2002-06-25 — — US disclosed
US-20020058707-A1 COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS INSMED INCORPORATED 2002-05-16 — — US disclosed
US-20020058701-A1 Compositions containing hypoglycemically active stilbenoids SHAMAN PHARMACEUTICALS 2002-05-16 — — US disclosed
WO-2002013811-A2 COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS INSMED INCORPORATED (US) 2002-02-21 — — WO disclosed
WO-2002014252-A2 COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS INSMED INCORPORATED (US) 2002-02-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058707-A1 COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS SLC5A2, SLC5A1, SLC2A1 ABCB1 1699/4885ABL1 2522/4885BCR 3675/4885
US-20100029647-A1 3,4,(5)-SUBSTITUTED TETRAHYDROPHYRIDINES REN, PAH, ACE ABCB1 504/4885ABL1 1240/4885BCR 3154/4885
US-20110092578-A1 Broad Spectrum Gram-Positive Antimicrobials and Anthelmintics with Efficacy Against Drug-Resistant Strains and Mycobacterium Species ABCC1, H1-3, H1-2 ABCB1 81/4885ABL1 619/4885BCR 249/4885
US-20110263560-A1 Organic Compounds REN, ACE, OTC ABCB1 398/4885ABL1 1288/4885BCR 1855/4885
US-20020058701-A1 Compositions containing hypoglycemically active stilbenoids SLC5A2, SLC5A1, SLC2A1 ABCB1 1699/4885ABL1 2522/4885BCR 3675/4885
US-20090312304-A1 ORGANIC COMPOUNDS REN, ACE, PIGO ABCB1 375/4885ABL1 1616/4885BCR 2286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.